Science, medicine, and the future: Genetics and cardiovascular risk
- 15 December 2001
- Vol. 323 (7326) , 1409-1412
- https://doi.org/10.1136/bmj.323.7326.1409
Abstract
Methods This review is based on our research and clinical experience in human genetics, pathology, and medicine. Citations for the topics discussed derive from literature searches in PubMed, OMIM (Online McKusick Inheritance in Man), and online US and European patent databases (USPTO and Esp@cenet respectively).This publication has 17 references indexed in Scilit:
- Outcome of case finding among relatives of patients with known heterozygous familialBMJ, 2000
- The 22q11 deletion syndromesHuman Molecular Genetics, 2000
- The use of long PCR to confirm three common alleles at the CYP2A6 locus and the relationship between genotype and smoking habitAnnals of Human Genetics, 2000
- Congenital Heart Disease Caused by Mutations in the Transcription Factor NKX2-5Science, 1998
- Association of Mutations in the Apolipoprotein B Gene with Hypercholesterolemia and the Risk of Ischemic Heart DiseaseNew England Journal of Medicine, 1998
- Cholesterol Reduction Yields Clinical BenefitCirculation, 1998
- Phenotypic Variation in Heterozygous Familial HypercholesterolemiaArteriosclerosis, Thrombosis, and Vascular Biology, 1998
- A pilot study of ex vivo gene therapy for homozygous familial hypercholesterolaemiaNature Medicine, 1995
- Genetic and environmental factors affecting the incidence of coronary artery disease in heterozygous familial hypercholesterolemia.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1991
- Familial risks of congenital heart defect assessed in a population‐based epidemiologic studyAmerican Journal of Medical Genetics, 1987